Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 13;104(24):e42820.
doi: 10.1097/MD.0000000000042820.

A case report and literature review on new-onset systemic lupus erythematosus leading to thrombocytopenia in a hemodialysis patient

Affiliations
Review

A case report and literature review on new-onset systemic lupus erythematosus leading to thrombocytopenia in a hemodialysis patient

Zhe Zhang et al. Medicine (Baltimore). .

Abstract

Rationale: Systemic lupus erythematosus (SLE) is a complex autoimmune disease that affects various organs. Disease activity in SLE may diminish following the initiation of dialysis in patients with end-stage renal disease.

Patient concern: We report the case of a 69-year-old female patient with a prior diagnosis of IgA nephropathy who developed SLE characterized by severe thrombocytopenia after hemodialysis.

Diagnoses: The patient presented with fever, rash, polyarthralgia, thrombocytopenia, hemolytic anemia, positive antinuclear antibodies, anti-nucleosome antibodies, anticardiolipin antibodies, anti-β2-glycoprotein I antibodies, and decreased complement C3 and C4 levels. She was diagnosed with SLE complicated by hematological damage and immune thrombocytopenia.

Interventions: The treatment included an intravenous infusion of 5% human immunoglobulin at 20 g/day for 5 days combined with an intravenous infusion of methylprednisolone at 500 mg/day for 3 days. Plasma exchange therapy was conducted a total of 3 times.

Outcomes: The patient was discharged with methylprednisolone and hydroxychloroquine treatment. The platelet count was stable, antinuclear antibody, anti-nucleosome antibody, antiphospholipid antibody, Coombs test, and complement C3 and C4 levels were normal after discharge.

Lessons: In patients with unexplained thrombocytopenia, the possibility of SLE should be considered even after hemodialysis initiation.

Keywords: case report; hemodialysis; systemic lupus erythematosus; thrombocytopenia.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
The renal pathological results of the patient. (A) HE staining results showing moderate mesangial proliferative IgA nephropathy with focal sclerosis. (B) Electron microscopy results confirming the diagnosis of IgA nephropathy.
Figure 2.
Figure 2.
Radiographic and CT scan findings of the patient. (A) X-ray on July 13, 2023. (B) X-ray on July 27, 2023. (C) and (D) Chest CT scan results showing interstitial pneumonia on August 9, 2023.
Figure 3.
Figure 3.
Clinical course during the treatment.

Similar articles

References

    1. Kuhn A, Bonsmann G, Anders HJ, Herzer P, Tenbrock K, Schneider M. The diagnosis and treatment of systemic lupus erythematosus. Dtsch Arztebl Int. 2015;112:423–32. - PMC - PubMed
    1. Boddaert J, Huong D, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltim). 2004;83:348–59. - PubMed
    1. Coplon NS, Diskin CJ, Petersen J, Swenson RS. The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. N Engl J Med. 1983;308:186–90. - PubMed
    1. Cheigh JS, Kim H, Stenzel KH, et al. Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity. Am J Kidney Dis. 1990;16:189–95. - PubMed
    1. Arvia R, Stincarelli MA, Manaresi E, Gallinella G, Zakrzewska K. Parvovirus B19 in rheumatic diseases. Microorganisms. 2024;12:1708. - PMC - PubMed

MeSH terms

Substances